Last updated:
Author(s):
Daisy C P Crick, Sarah L Halligan, George Davey Smith, Golam M Khandaker, Hannah J Jones
Publish date:
11 June 2025
Journal:
International Journal of Epidemiology
PubMed ID:
40550517

Abstract

BACKGROUND: Omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acids (PUFAs) are thought to have anti- and pro-inflammatory roles, respectively, and influence the risk of various chronic diseases. However, it is unclear whether these associations are causal.

METHODS: We examined the associations of dietary polyunsaturated FAs with biomarkers of systemic inflammation: C-reactive protein (CRP), glycoprotein acetyls (GlycA), and interleukin 6 (IL-6) in two cohort datasets-Avon Longitudinal Study of Parents and Children (N = 2802) and UK Biobank (N = 12 401)-by using multivariable analyses. We investigated causality by using two-sample Mendelian randomization (MR). In addition to the inverse-variance weighted (IVW) method, we used sensitivity analyses to strengthen the causal inference. We conducted multivariable MR (MVMR) to investigate the causal effects of n-3 and n-6 on inflammation, accounting for the low-density lipoprotein (LDL) cholesterol, triglycerides, monounsaturated FAs, and saturated FAs.

RESULTS: Cohort analyses show a positive association between the n-6:n-3 ratio and each biomarker. Total n-3 and n-6 PUFAs were associated with higher GlycA levels [mean difference = 0.33; 95% confidence interval (CI) = 0.29, 0.36, and 0.52; 95% CI = 0.48, 0.55, respectively]. The MR results suggest that total n-3 FAs cause higher circulating CRP (IVW = 0.09; 95% CI = 0.03, 0.16) and GlycA levels (0.12; 95% CI = 0.04, 0.21). The positive association between n-3 FAs and GlycA remained in the MVMR analysis after accounting for LDL cholesterol, triglycerides, monounsaturated FAs, and saturated FAs.

CONCLUSION: We find no convincing evidence of a simple pro- and anti-inflammatory dichotomy regarding the function of n-6 and n-3 PUFAs. Further research is needed to better understand the mechanisms underlying the effects of PUFAs on specific immune biomarkers.

Related projects

Biomarkers measured from blood samples are indicative of the risk for many chronic diseases, such as heart disease and diabetes. We intend to measure blood…

Institution:
Nightingale Health Ltd, Finland

This research project aims to use the wealth of biomedical data from the UK Biobank project to better understand the causes and consequences of disease.

Institution:
University of Bristol, Great Britain

All projects